These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15154750)

  • 1. De novo generation of molecular structures using optimization to select graphs on a given lattice.
    Bywater RP; Poulsen TA; Røgen P; Hjorth PG
    J Chem Inf Comput Sci; 2004; 44(3):856-61. PubMed ID: 15154750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular complexity analysis of de novo designed ligands.
    Boda K; Johnson AP
    J Med Chem; 2006 Oct; 49(20):5869-79. PubMed ID: 17004702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization.
    Hartenfeller M; Proschak E; Schüller A; Schneider G
    Chem Biol Drug Des; 2008 Jul; 72(1):16-26. PubMed ID: 18564216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK; Fox T; Crocker I
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing active template molecules by combining computational de novo design and human chemist's expertise.
    Lameijer EW; Tromp RA; Spanjersberg RF; Brussee J; Ijzerman AP
    J Med Chem; 2007 Apr; 50(8):1925-32. PubMed ID: 17367122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo ligand design to an ensemble of protein structures.
    Todorov NP; Buenemann CL; Alberts IL
    Proteins; 2006 Jul; 64(1):43-59. PubMed ID: 16555306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tagged fragment method for evolutionary structure-based de novo lead generation and optimization.
    Liu Q; Masek B; Smith K; Smith J
    J Med Chem; 2007 Nov; 50(22):5392-402. PubMed ID: 17918924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flux (2): comparison of molecular mutation and crossover operators for ligand-based de novo design.
    Fechner U; Schneider G
    J Chem Inf Model; 2007; 47(2):656-67. PubMed ID: 17315990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ab initio crystal structure prediction-I. Rigid molecules.
    Karamertzanis PG; Pantelides CC
    J Comput Chem; 2005 Feb; 26(3):304-24. PubMed ID: 15622548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.
    Seebach D; Beck AK; Bierbaum DJ
    Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Representation of the molecular topology of cyclical structures by means of cycle graphs. 3. Hierarchical model of screening of chemical databases.
    Luque Ruiz I; García GC; Gómez-Nieto MA
    J Chem Inf Comput Sci; 2004; 44(6):1903-11. PubMed ID: 15554659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of molecular graphs for QSAR studies: an approach based on supergraphs.
    Melnikov AA; Palyulin VA; Zefirov NS
    J Chem Inf Model; 2007; 47(6):2077-88. PubMed ID: 17958347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flux (1): a virtual synthesis scheme for fragment-based de novo design.
    Fechner U; Schneider G
    J Chem Inf Model; 2006; 46(2):699-707. PubMed ID: 16563000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Representation of the molecular topology of cyclical structures by means of cycle graphs. 2. Application to clustering of chemical databases.
    Luque Ruiz I; Cerruela García G; Gómez-Nieto MA
    J Chem Inf Comput Sci; 2004; 44(4):1383-93. PubMed ID: 15272846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recore: a fast and versatile method for scaffold hopping based on small molecule crystal structure conformations.
    Maass P; Schulz-Gasch T; Stahl M; Rarey M
    J Chem Inf Model; 2007; 47(2):390-9. PubMed ID: 17305328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailor-made force fields for crystal-structure prediction.
    Neumann MA
    J Phys Chem B; 2008 Aug; 112(32):9810-29. PubMed ID: 18642947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and selection of novel estrogen receptor ligands using the de novo structure-based design tool, SkelGen.
    Firth-Clark S; Willems HM; Williams A; Harris W
    J Chem Inf Model; 2006; 46(2):642-7. PubMed ID: 16562994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore identification, in silico screening, and virtual library design for inhibitors of the human factor Xa.
    Krovat EM; Frühwirth KH; Langer T
    J Chem Inf Model; 2005; 45(1):146-59. PubMed ID: 15667140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal engineering on industrial diaryl pigments using lattice energy minimizations and X-ray powder diffraction.
    Schmidt MU; Dinnebier RE; Kalkhof H
    J Phys Chem B; 2007 Aug; 111(33):9722-32. PubMed ID: 17672490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A third blind test of crystal structure prediction.
    Day GM; Motherwell WD; Ammon HL; Boerrigter SX; Della Valle RG; Venuti E; Dzyabchenko A; Dunitz JD; Schweizer B; van Eijck BP; Erk P; Facelli JC; Bazterra VE; Ferraro MB; Hofmann DW; Leusen FJ; Liang C; Pantelides CC; Karamertzanis PG; Price SL; Lewis TC; Nowell H; Torrisi A; Scheraga HA; Arnautova YA; Schmidt MU; Verwer P
    Acta Crystallogr B; 2005 Oct; 61(Pt 5):511-27. PubMed ID: 16186652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.